Antimicrobial Potential of Probiotic or Potentially Probiotic Lactic Acid Bacteria, the First Results of the International European Research Project PROPATH of the PROEUHEALTH Cluster

Article English OPEN
Vuyst, Luc De ; Makras, Lefteris ; Avonts, Lazlo ; Holo, Helge ; Yi, Qing ; Servin, Alain ; Fayol-Messaoudi, Domitille ; Berger, Cédric ; Zoumpopoulou, Georgia ; Tsakalidou, Effue ; Sgouras, Dionyssios ; Martinez-Gonzales, Beatriz ; Panayotopoulou, Effie ; Mentis, Andreas ; Smarandache, Diana ; Savu, Lorand ; Thonart, Philippe ; Nes, Ingolf (2011)
  • Publisher: Microbial Ecology in Health and Disease
  • Journal: Microbial Ecology in Health and Disease (issn: 1651-2235, eissn: 1651-2235)
  • Related identifiers: doi: 10.3402/mehd.v16i2-3.7936

The EU-funded PROPATH project addresses the important health issue of prevention of gastrointestinal disorders through probiotics and prebiotics. Seven European laboratories are co-operating in this project, which aims to isolate and characterize the relevant antimicrobial agents to combat Gram-negative bacteria including Helicobacter pylori and Salmonella enterica serovar Typhimurium. In this paper, the first results on the screening for probiotic or potentially probiotic lactobacilli that exhibit antimicrobial activity towards these Gram-negative pathogenic bacteria are presented. Spot-on-lawn assays, well-diffusion assays and time-kill studies were performed among the lactic acid bacteria strains that were either collected from fermented foods and faeces (breast-fed babies, infants and animals) or isolated from commercial products to investigate whether any of the collected strains were inhibiting growth of or were killing certain indicator bacteria. Strains inhibiting the gastrointestinal pathogens mentioned above were found. Evidence has been obtained that compounds different from organic acids are produced.Key words: probiotics, antimicrobial agents, gastrointestinal pathogens.
  • References (32)
    32 references, page 1 of 4

    1. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003; 361: 512 /9.

    2. Holzapfel WH, Haberer P, Snel J, Schillinger U, Huis in't Veld JH. Overview of gut flora and probiotics. Int J Food Microbiol 1998; 41: 85 /101.

    3. Gomes AMP, Malcata FX. Bifidobacterium spp. and Lactobacillus acidophilus : biological, biochemical, technological and therapeutical properties relevant for use as probiotics. Trends Food Sci Tech 1999; 10: 139 /57.

    4. Mercenier A, Pavan S, Pot B. Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr Pharm Des 2003; 9: 175 /91.

    5. De Vuyst L, Avonts L, Makras L. Probiotics, prebiotics and gut health. In: Remacle C, Reusens B, eds. Functional Foods, Ageing and Degenerative Disease. Cambridge: Woodhead Publishing, 2004 (in press).

    6. Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr 2001; 73: 430S /6S.

    7. Michetti P, Dorta G, Wiesel PH, Brassart D, Verdu E, Herranz M, Felley C, Porta N, Rouvet M, Blum AL, Corthesy-Theulaz I. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii ) La1 on Helicobacter pylori infection in humans. Digestion 1999; 60: 203 /9.

    8. Felley CP, Corthesy-Theulaz I, Rivero JL, Sipponen P, Kaufmann M, Bauerfeind P, Wiesel PH, Brassart D, Pfeifer A, Blum AL, Michetti P. Favourable effect of an acidified milk (LC-1) on Helicobacter pylori gastritis in man. Eur J Gastroenterol Hepatol 2001; 13: 25 /9.

    9. Gotteland M, Cruchet S. Suppressive effect of frequent ingestion of Lactobacillus johnsonii La1 on Helicobacter pylori colonization in asymptomatic volunteers. J Antimicrob Chemother 2003; 51: 1317 /9.

    10. Pipkin GA, Williamson R, Wood JR. One-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori . Aliment Pharmacol Ther 1998; 12: 823 /37.

  • Metrics
    No metrics available
Share - Bookmark